Terms ending in 2035
Every in-force patent on CureVac AG's record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,201,680 | Nucleic Acid Comprising or Coding for a Histone Stem-Loop and a Poly(A) Sequence or a Polyadenylation Signal for Increasing the Expression of an Encoded Pathogenic Antigen In force · High confidence | Curevac SE | In force | High confidence | |
| US 10,369,216 | Polymeric Carrier Cargo Complex for Use as an Immunostimulating Agent or as an Adjuvant In force · Medium confidence | Curevac SE | In force | Medium confidence | |
| US 10,017,826 | Method for Producing RNA In force · High confidence | Curevac Manufacturing GmbH | In force | High confidence | |
| US 10,898,584 | Modified RNA with Decreased Immunostimulatory Properties In force · High confidence | Curevac SE | In force | High confidence | |
| US 10,837,039 | Methods and Means for Enhancing RNA Production In force · High confidence | Curevac Manufacturing GmbH | In force | High confidence | |
| US 11,286,492 | Artificial Nucleic Acid Molecules for Improved Protein Expression In force · High confidence | Curevac SE | In force | High confidence | |
| US 11,345,920 | Artificial Nucleic Acid Molecules for Improved Protein Expression In force · High confidence | Curevac SE | In force | High confidence | |
| US 11,761,009 | Artificial Nucleic Acid Molecules for Improved Protein Expression In force · High confidence | Curevac SE | In force | High confidence | |
| US 12,442,005 | Artificial Nucleic Acid Molecules for Improved Protein Expression In force · High confidence | CureVac SE | In force | High confidence |
9 of 9 patents shown. Soonest term end first, then patent number.
7 of these are in force and held by CureVac AG.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.